Boryung Pharm (003850)

Currency in KRW
9,310
+310(+3.44%)
Delayed Data·
003850 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
9,1509,340
52 wk Range
7,68010,800
Key Statistics
Bid/Ask
9,310.00 / 9,320.00
Prev. Close
9,000
Open
9,210
Day's Range
9,150-9,340
52 wk Range
7,680-10,800
Volume
24.92K
Average Volume (3m)
224.46K
1-Year Change
7.2581%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
003850 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13,000
Upside
+39.63%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Boryung Pharm News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

Employees
1533

Compare 003850 to Peers and Sector

Metrics to compare
003850
Peers
Sector
Relationship
P/E Ratio
11.8x13.5x−0.4x
PEG Ratio
−0.480.060.00
Price/Book
0.9x0.9x2.6x
Price / LTM Sales
0.7x0.6x3.1x
Upside (Analyst Target)
44.3%42.6%58.8%
Fair Value Upside
Unlock17.6%9.2%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 13,000
(+39.63% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 766.00%
Dividend Yield
1.73%
Industry Median 0.89%
Annualised payout
160.00
Paid annually
5-Years Growth
+5.71%
Growth Streak

Earnings

Latest Release
02/02/2026
EPS / Forecast
250.92 / --
Revenue / Forecast
263.5B / 262B
EPS Revisions
Last 90 days

People Also Watch

7,770
137310
+1.57%
24,100
003090
+3.43%
30,900
001060
+2.32%
46,450
281820
+5.81%
17,750
069260
-1.22%

FAQ

What Is the Boryung Pharm (003850) Share Price Today?

The Boryung Pharm stock price today is 9,310 KRW.

What Stock Exchange Does Boryung Pharm (003850) Trade On?

Boryung Pharm is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for Boryung Pharm?

The stock symbol (also called a 'ticker') for Boryung Pharm is "003850."

Does Boryung Pharm Pay Dividends? What’s The Current 003850 Dividend Yield?

Yes, 003850 Pays Dividends to its Shareholders. The current Boryung Pharm dividend yield is 1.78%.

What Is the Current Boryung Pharm Market Cap?

As of today, Boryung Pharm market cap is 815.24B KRW.

What Is Boryung Pharm's (003850) Earnings Per Share (TTM)?

The Boryung Pharm EPS is currently 766 (Trailing Twelve Months).

When Is the Next Boryung Pharm Earnings Date?

Boryung Pharm's next earnings report will be released on 05/05/2026.

Is 003850 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Boryung Pharm moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Boryung Pharm Stock Split?

Boryung Pharm has split 19 times. (See the 003850 stock split history page for full effective split date and price information.)

How Many Employees Does Boryung Pharm Have?

Boryung Pharm has 1533 employees.

What is the current trading status of Boryung Pharm (003850)?

As of 01/04/2026, Boryung Pharm (003850) is trading at a price of 9,310 KRW, with a previous close of 9,000 KRW. The stock has fluctuated within a day range of 9,150 KRW to 9,340 KRW, while its 52-week range spans from 7,680 KRW to 10,800 KRW.

What Is Boryung Pharm (003850) Price Target According to Analysts?

The average 12-month price target for Boryung Pharm is 13,000 KRW, with a high estimate of 13000 KRW and a low estimate of 13000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +39.63% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.